Ascendis
A phase 3 trial investigating the efficacy and safety of weekly lonapegsomatropin compared to daily somatropin in children with short stature or growth failure due to growth hormone sufficient disorders.
Status: Coming soon
Contact: ECRU@childrens.harvard.edu